Poland
· Delayed Price · Currency is PLN Krakchemia Statistics
Total Valuation
Krakchemia has a market cap or net worth of PLN 10.26 million. The enterprise value is 14.64 million.
| Market Cap | 10.26M |
| Enterprise Value | 14.64M |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
| Earnings Date | Nov 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Krakchemia has 9.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 9.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 57.73% |
| Owned by Institutions (%) | n/a |
| Float | 3.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.13 |
| EV / Sales | 0.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.28% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | -379,441 |
| Employee Count | 34 |
| Asset Turnover | 2.31 |
| Inventory Turnover | 13.47 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +207.26% in the last 52 weeks. The beta is 0.41, so Krakchemia's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +207.26% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 0.49 |
| Relative Strength Index (RSI) | 46.00 |
| Average Volume (20 Days) | 435,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krakchemia had revenue of PLN 56.71 million and -12.90 million in losses. Loss per share was -1.43.
| Revenue | 56.71M |
| Gross Profit | 7.94M |
| Operating Income | -3.64M |
| Pretax Income | -12.98M |
| Net Income | -12.90M |
| EBITDA | -2.64M |
| EBIT | -3.64M |
| Loss Per Share | -1.43 |
Balance Sheet
The company has 427,000 in cash and 4.81 million in debt, giving a net cash position of -4.38 million or -0.49 per share.
| Cash & Cash Equivalents | 427,000 |
| Total Debt | 4.81M |
| Net Cash | -4.38M |
| Net Cash Per Share | -0.49 |
| Equity (Book Value) | -53.65M |
| Book Value Per Share | -5.96 |
| Working Capital | -59.65M |
Cash Flow
| Operating Cash Flow | -1.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 14.00%, with operating and profit margins of -6.42% and -22.75%.
| Gross Margin | 14.00% |
| Operating Margin | -6.42% |
| Pretax Margin | -22.89% |
| Profit Margin | -22.75% |
| EBITDA Margin | -4.65% |
| EBIT Margin | -6.42% |
| FCF Margin | n/a |
Dividends & Yields
Krakchemia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -125.74% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Krakchemia has an Altman Z-Score of -6.12. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.12 |
| Piotroski F-Score | n/a |